Nurr-1 induction of a dopaminergic neuronal fate in a neural...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S375000, C435S325000

Reexamination Certificate

active

07465582

ABSTRACT:
The invention relates to the induction of the neuronal fate in neural stem cells or neural progenitor cells. The inventors have found that a neuronal fate in a neural stem cell or neural progenitor cell can be induced by expressing Nurr1 above basal levels within the cell. Nurr1 is a transcription factor of the thyroid hormone/retinoic acid nuclear receptor superfamily. It is shown herein that the expression of Nurr1 above basal levels in neural stem cells or neural progenitor cells increases the proportion of the cells which differentiate toward a neural fate. It has been found that in particular, dopaminergic neural stem cells or progenitor cells by a process including expression of Nurr1 above basal levels in the cells and contact of the cells with one or more factors supplied by or derived from Type I astrocytes of the ventral mesencephalon.

REFERENCES:
patent: 5981165 (1999-11-01), Weiss et al.
patent: 6284539 (2001-09-01), Bowen et al.
patent: 6312949 (2001-11-01), Sakurada et al.
patent: 6833269 (2004-12-01), Carpenter
patent: 2002/0114788 (2002-08-01), Isacson et al.
patent: WO 96 09543 (1996-05-01), None
patent: WO 9615224 (1996-05-01), None
patent: 00/58451 (2000-10-01), None
patent: 02/09733 (2002-02-01), None
Verma, et al. Nature, Sep. 1997, vol. 389, pp. 239-242.
Palu, et al. J. Biotechnology, 1999, vol. 68, pp. 1-13.
Luo, et al. Nature Biotechnology, 2000, vol. 18, pp. 33-37.
Fox, Jeffrey. ASM News, Feb. 2000, vol. 66, No. 2, pp. 1-3.
Hsich, et al. Human Gene Therapy, Mar. 2002, vol. 13, pp. 579-604.
Tenenbaum L, Chtarto A, Lehtonen E, Blum D, Baekelandt V, Velu T, Brotchi J, Levivier M. 2002. Neuroprotective gene therapy for Parkinson's disease. Curr Gene Ther. 2(4):451-83.
Takeshima T, Shimoda K, Sauve Y Commissiong, JW. 1994 .Astrocyte dependent and independent phases of the development and survival of rat embryonic day 14 mesencephalic dopaminergic neurons in culture. Neuroscience 60(3):809-823.
Gerlach M, Braak H, hartmann A, Jost WH , Odin P, Priller J, Schwarz J. 2002.Current state of stem cell research for the treatment of Parkinson's disease. J Neurol. Oct. 2002;249 Suppl 3:III/33-5.
Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem cells.Nature. May 2, 2002;417(6884):39-44.
E. Arenas et al.,Nurr1 overexpression enriches for neuronal phenotype in multipotent, neural stem-like cells, Society for Neuroscience Abstracts, 28thAnnual Meeting of the Society for Neuroscience, Part 2, Los Angeles, US , Nov. 7-12, 1998, vol. 24, 1998, p. 1531, Abstract 606.10.
D.M. Panchision et al.,An immortalized type-1 astrocyte of mesencephalic origin; source of a dopaminergic neurotrophic factor. Journal of Molecular Neuroscience, vol. 11, No. 3, 1998, pp. 209-221.
T. Takeshima et al.,Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture. Neuroscience, vol. 60, No. 3, 1994, pp. 809-823.
A. Gritti et al.,Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precusors cells of the adult mouse CNS. Neuroscience letters, vol. 185, No. 3, 1995, pp. 151-154.
O. Saucedo-Cardenas et al.,Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. PNAS USA, vol. 95, Mar. 1998, pp. 4013-4018.
J. Wagner et al.,Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nature Biotechnology, vol. 17, Jul. 1999, pp. 653-659.
K. Sakurada et al.,Nurr1, an orphan nuclear receptor ia a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development, vol. 126, Sep. 1999, pp. 4017-4026.
S. Denis-Donini et al.,Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature, vol. 307, Feb. 1984, pp. 641-643.
Haque NS, LeBlanc CJ, Isacson O. Differential dissection of the rat E16 ventral mesencephalon and survival and reinnervation of the 6-OHDA-lesioned striatum by a subset of aldehyde dehydrogenase-positive TH neurons. Cell Transplant. May-Jun. 1997;6(3):239-48.
Åkerud P., Canals J., Snyder E.Y. and Arenas E. (2001) Neuroprotection through delivery of GDNF by neural stem cells in a mouse model of Parkinson's disease. Journal of Neuroscience, 21:8108-8118.
Åkerud P., Holm P.C., Castelo-Branco G., Sousa K., Rodriguez FJ and Arenas E. (2002) Persephin-overexpressing neural stem cells regulate the function of nigrostriatal dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease. Molecular and Cellular Neuroscience, 21: 205-222.
Freed CR, Leehey MA, Zawada M, Bjugstad K, Thompson L, Breeze RE. Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation? J Neurol. Oct. 2003;250 Suppl 3:III44-6.
Dunnett SB, Björklund A, Lindvall O. (2001) Cell therapy in Parkinson's disease—stop or go? Nat Rev Neurosci. 2001, 2(5):365-9.
Von Bohlen und Halbach OB, Schober A, Krieglstein K. Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog Neurobiol. Jun. 2004;73(3):151-77.
Schwarz J. Rationale for dopamine agonist use as monotherapy in Parkinson's dissease. Curr Opin Neurol. Dec. 2003;16 Suppl 1:S27-33.
Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. May 2003;9(5):589-95.
Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in promate models of Parkinson's disease. Science 290(5492): 767-773.
Bjorklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. Jul. 2003;2(7):437-45.
Wagner J., Åkerud P., Castro D., Holm P C., Canals J M., Snyder E Y., Perlmann T. and Arenas E. (a999). Induction of a Midbrain Dopaminergic Phenotype in Nurr1-Overexpressing Neural Stem Cells. Nature Biotechnology, 17: 653-659.
Cochen V, Ribeiro MJ, Nguyen JP, Gurruchaga JM, Villafane G, Loc'h C, Defer G, Samson Y, Peschanski M, Hantraye P, Cesaro P, Remy P. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord. Aug. 2003;18(8):928-32.
Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol. Aug. 2001;60(8):741-52.
Piccini P, Lindvall O, Bjorklund A, brundin P, Hagell P, Ceravolo R, Oertel W, Quinn N, Samuel M, Rehncrona S, Widner H, Brooks DJ. Related Articles, Links Abstract Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol. Nov. 2000;48(5):689-95.
Kirik, D., et al., “Localized striatal delivery of GDNF as a treatment for Parkinson disease”, Nature Neuroscience, vol. 7: p. 105-110, (2004).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nurr-1 induction of a dopaminergic neuronal fate in a neural... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nurr-1 induction of a dopaminergic neuronal fate in a neural..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nurr-1 induction of a dopaminergic neuronal fate in a neural... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4027456

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.